Satoris Named Global Distributor of RBM's 189-marker DiscoveryMAP Neurology Panel | GenomeWeb

This story originally ran on Aug. 4.

Satoris this week said that it will distribute Rules-Based Medicine's panel of 189 protein biomarkers for neurology research.

RBM launched the service-based biomarker panel, called DiscoveryMAP, in June. The same month, Satoris launched three neurology biomarker panels of its own, one for differentiating patients with Alzheimer's disease from other forms of dementia, and two panels for plasma proteins associated with neurodegeneration and neuroinflammation

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In Science this week: genetic analysis of pollutant-tolerant fish, and more.

Researchers have found a rare carbapenem resistance gene on a US pig farm, NBC News reports.

New York officials are considering the use of a familial DNA search to get a lead on a suspect in the strangulation death of a runner.

NIH Director Francis Collins has selected a retired Army major general and cardiologist for the CEO spot at the agency's embattled Clinical Center.